Chris Markoch

Chris Markoch

Chris Markoch is a freelance financial writer who brings over 25 years in sales and marketing to help find the story behind the stock. Chris starts by asking the question, “So what?” and then uses fundamental and (some) technical analysis to add depth to that insight.

Stepping back from the “what” allows Chris to bring perspective that helps investors make wise decisions based on their risk tolerance and investing timeline.

Markoch would describe his writing as being for investors more than traders. He looks at equities through a long-term lens and that is reflected in his writing.

In addition to his articles on InvestorPlace, you can also find Chris’ writing on MarketBeat.com where he has collaborated on the e-book “5 Investing Trends That Will Define the Market in 2022.” You can find Chris on LinkedIn and on Twitter.

Recent Articles

Buying Ulta Stock Is a Timing Gamble

If the economy bounces back to normal after the coronavirus fades, Ulta stock today represents a great discount. However, this is a huge assumption to make.

GE Stock Needs More Than Wishful Thinking to Stay Alive

Even without the pandemic, GE stock was a challenging bet on an unlikely recovery. But given the economic damage, it's hard to have much hope for General Electric.

Have Investors Missed the Rally for XOM Stock?

XOM stock may be a quality dividend play on a great discount. However, you should also be prepared for some choppy waters ahead.

3 Healthcare Stocks to Buy for AI and Big Data

Healthcare stocks are in the spotlight as the coronavirus brings to light the importance of collecting data and using it to predict outcomes.

DPZ Stock Has Become a Timely Defensive Stock

The pizza chain is delivering food to shut-in Americans and jobs to displaced workers, making DPZ stock a viable, "feel-good" investment.